6678.T
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. 6678.T is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
6678.T is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥9,061,387,000, representing a significant portion of its total assets. The liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations. The current ratio of 4.79 further supports this, showing that the company has more than four times the current assets to cover its current liabilities.
Profitability metrics indicate a moderate return on equity (ROE) of 6.98% and a return on assets (ROA) of 5.6%. These figures are in line with the industry's preferred metrics, suggesting the company is performing at a level consistent with its peers. The operating margin, calculated as operating income divided by revenue, is 13.3%, which is a strong indicator of efficient operations.
The company's revenue is primarily concentrated in the medical equipment, supplies, and distribution segment, with no disclosed geographic breakdown. This concentration may expose the company to specific market risks, particularly in the healthcare sector, where demand can be influenced by regulatory changes and public health events.
Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. Historical revenue data shows a consistent performance, and the company's strong liquidity position supports its ability to sustain operations and invest in future growth opportunities.
Risk factors for the company are currently low, with no immediate filing-based liquidity or dilution flags detected. The absence of long-term debt and a low debt-to-equity ratio of 0.0 further reduce financial risk. However, the company should remain vigilant about potential regulatory changes in the healthcare sector that could impact its operations.
Recent events, including filings and transcripts, have not indicated any significant changes in the company's strategic direction or financial health. The company continues to operate with a strong balance sheet and a clear focus on its core business in the healthcare equipment and supplies market.
- The company has a strong liquidity position, supported by a high current ratio and significant cash reserves.
- Profitability metrics are in line with industry standards, indicating efficient operations and a moderate return on equity.
- Revenue is concentrated in the medical equipment, supplies, and distribution segment, which may expose the company to sector-specific risks.
- The company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year.
- Risk factors are currently low, with no immediate liquidity or dilution concerns.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 6678.T Market data — financials · 2026-05-27